CPN1 and Alzheimer disease: This relationship was first cited in the seminal study by Balin et al. [23] that demonstrated that metabolically active Cpn was found by immunohistochemical, electron microscopic, and PCR techniques to be localized to areas of AD pathology in 17 of 19 post-mortem AD brains compared to 1 of 19 non-AD control brains.